Falck Medical, INC, an FDA registered
corporation, is a leading developer of innovative technologies
with applications in the diagnosis and treatment of ischemic
retinopathies, age related retinopathies and glaucoma. All of
the technologies are covered by multiple national/international
patents and patent pending applications.
To learn more about these innovative technologies please contact
us."Deus ex
Machina"
Scientific Advisory
Board Members:
Francis Y. Falck, Jr., MD, PhD, MS,
Assistant Clinical Professor, University of Connecticut School
of Medicine
David Epstein, MD, Professor and Chair, Department of
Ophthalmology, Duke University School of Medicine
Elias Reichel, MD, Vice Chairman, Department of Ophthalmology,
Tufts University School of Medicine |
